IDEAYA Biosciences annual revenue
2019
2020
2021
2022
2023
2024
2025
IDEAYA Biosciences reported $218.7M in revenue for fiscal 2025, an increase of 3024.43% from the previous fiscal year.
View full IDEAYA Biosciences company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $218.7M | $211.7M | +3024.43% |
| 2024 | 2024-12-31 | $7.0M | −$16.4M | −70.07% |
| 2023 | 2023-12-31 | $23.4M | −$27.5M | −54.08% |
| 2022 | 2022-12-31 | $50.9M | $23.0M | +82.28% |
| 2021 | 2021-12-31 | $27.9M | $8.4M | +43.01% |
| 2020 | 2020-12-31 | $19.5M | $19.5M | — |
| 2019 | 2019-12-31 | $0 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.9M | $8.9M | — |
| Q1 2026 | 2026-03-31 | $6.6M | — | — |
| Q4 2025 | 2025-12-31 | $10.9M | $3.9M | +55.37% |
| Q3 2025 | 2025-09-30 | $207.8M | $207.8M | — |
| Q2 2025 | 2025-06-30 | $0 | $0 | — |
| Q4 2024 | 2024-12-31 | $7.0M | $3.1M | +78.43% |
| Q3 2024 | 2024-09-30 | $0 | −$8.0M | −100.00% |
| Q2 2024 | 2024-06-30 | $0 | −$3.5M | −100.00% |
| Q1 2024 | 2024-03-31 | $0 | −$7.9M | −100.00% |
| Q4 2023 | 2023-12-31 | $3.9M | −$99,000 | −2.46% |
| Q3 2023 | 2023-09-30 | $8.0M | −$21.7M | −72.94% |
| Q2 2023 | 2023-06-30 | $3.5M | −$2.3M | −39.43% |
| Q1 2023 | 2023-03-31 | $7.9M | −$3.5M | −30.63% |
| Q4 2022 | 2022-12-31 | $4.0M | $1.1M | +35.79% |
| Q3 2022 | 2022-09-30 | $29.7M | $20.7M | +230.87% |
| Q2 2022 | 2022-06-30 | $5.9M | −$2.9M | −33.18% |
| Q1 2022 | 2022-03-31 | $11.4M | $4.1M | +56.74% |
| Q4 2021 | 2021-12-31 | $3.0M | — | — |
| Q3 2021 | 2021-09-30 | $9.0M | $9,000 | +0.10% |
| Q2 2021 | 2021-06-30 | $8.8M | — | — |
| Q1 2021 | 2021-03-31 | $7.2M | — | — |
| Q3 2020 | 2020-09-30 | $9.0M | — | — |
Over the last five reported fiscal years, revenue grew from $19.5M to $218.7M, a compound annual growth rate of 62.11%. IDEAYA Biosciences's latest reported quarter, Q2 2026, generated $8.9M in revenue.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review IDEAYA Biosciences source filings ↗